Who are the key players in North America Long Read Sequencing Market industry?

Key players include Pacific Biosciences, which is renowned for its SMRT sequencing technology; Oxford Nanopore Technologies, a leader in nanopore-based sequencing; Illumina, an innovator in genomics; Agilent Technologies, providing sequencing solutions; and BGI Genomics, a significant contributor to genomic research and sequencing platforms.

What is the North America Long Read Sequencing Market growth?

The North America Long Read Sequencing Market has experienced robust growth, driven by increasing adoption in genomic research. In 2023, Pacific Biosciences announced significant revenue growth, fueled by rising demand for high-throughput and accurate sequencing needed in clinical diagnostics and genetic research.

Which segment accounted for the largest North America Long Read Sequencing Market share?

The human genomics and clinical research application segment captured the largest market share. The widespread use of long read sequencing to identify genetic disorders, improve disease diagnosis, and advance personalized medicine has driven adoption among research institutes and healthcare organizations across North America.

What are the factors driving the North America Long Read Sequencing Market?

Major factors include advancements in sequencing technologies, increasing R&D investment, and growing applications in precision medicine. For example, Illumina’s innovations in sequencing workflows have accelerated the adoption of long read platforms in comprehensive genomic analysis and rare disease diagnostics.

Which type accounted for the largest North America Long Read Sequencing Market share?

Single-Molecule Real-Time (SMRT) sequencing dominated the market, owing to its high accuracy and capability to detect complex genetic variations. Pacific Biosciences’ SMRT technology is widely used for de novo genome assemblies, full-length RNA sequencing, and structural variation studies across academic and clinical research.

Home Healthcare

North America Long Read Sequencing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Long Read Sequencing Market
Brand: Bussiness Insights

North America Long Read Sequencing Market: by Type (Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Synthetic Long-Read Sequencing, Others), Application (De Novo Sequencing, Variant Detection, Transcriptome Analysis, Epigenetics, Cancer Genomics, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Research Institutes, Hospitals, Others), Technology (SMRT Sequencing, Nanopore Sequencing, Linked-Read Sequencing, Synthetic Long-Read Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20510 | Author: Sophia

RD TOC Segmentation Research Methodology Request For Free Sample Copy

North America Long Read Sequencing Market Analysis 2025–2035

The North America Long Read Sequencing Market is experiencing robust growth, driven by breakthroughs in genomics and expanding applications in clinical diagnostics and research. Technologies like SMRT and nanopore sequencing are increasingly adopted for their ability to deliver comprehensive genomic insights, supporting precision medicine, cancer genomics, and rare disease identification. A dynamic landscape marked by rapid product innovation and strategic collaborations among leading players underpins market expansion, while the sector continues to overcome technical and regulatory challenges.

Latest Market Dynamics

Key Drivers

Technological advancements in long read sequencing, including improved accuracy of SMRT and nanopore systems, are accelerating adoption rates. For example, PacBio introduced enhanced chemistries in 2024, boosting throughput and cost efficiency.

Integration of AI with long read sequencing for automated variant detection is gaining traction. Illumina, in alliance with multiple research institutions, launched an AI-driven platform in July 2024, optimizing data interpretation speed and accuracy.
Increasing deployment of cloud-based genomic analysis solutions is notable. BGI Genomics expanded its cloud services in August 2024, facilitating seamless long read data sharing and analytics for researchers across North America.

Adoption in clinical and diagnostic settings remains a key opportunity. Roche collaborated with major hospital networks in September 2024 to implement long read sequencing for routine diagnostic workflows, targeting oncology and hereditary disease panels.
Expanding research funding for human genomic projects presents additional market opportunities. The NIH’s Freshwater Genomics Initiative, launched in October 2024, leverages long read sequencing to understand genetic susceptibility to environmental factors.

High operational and instrument costs persist as barriers. Quantapore’s recent attempt to scale mid-cost platforms highlights ongoing struggles to balance affordability and technology sophistication.
Complex data analysis and storage requirements challenge scalability. Genapsys, for example, invested in new bioinformatics tools in November 2024 to simplify large-scale long read sequencing dataset management.

The long read sequencing market in North America showcases a dominant share for Single-Molecule Real-Time (SMRT) Sequencing, owing to its matured applications across research, clinical, and diagnostics. Nanopore sequencing closely follows, gaining traction for field deployment and portable workflows. The presence of synthetic and hybrid sequencing technologies reflects the market’s inclination towards comprehensive genome coverage and improved accuracy. As innovation continues, the market mix is expected to gradually shift with the advancement of more accessible and cost-effective solutions.

De Novo sequencing accounts for the highest proportion of applications in the North America market, as it remains vital for assembling new genomes without reference data. Cancer genomics is witnessing rapid growth, reflecting the demand for precision oncology solutions and actionable insights from complex cancer genomes. Variant detection continues to be crucial, especially in hereditary disease research and clinical diagnostics, ensuring comprehensive genomic understanding.

The North America Long Read Sequencing Market has demonstrated significant revenue growth from 2020 through 2025, with an upswing from 485 Million USD in 2020 to an estimated 1,192 Million USD in 2025. Projected forecasts highlight further acceleration, reaching approximately 4,980 Million USD by 2035. Growth is attributed to technological innovations, broadening clinical applications, and increased research funding. The upward trajectory reflects expanding adoption beyond academic research into mainstream diagnostics and personalized healthcare.

Year-over-year growth rates in the North America Long Read Sequencing Market have been robust, peaking during initial adoption phases and stabilizing as the technologies mature. From 2020 to 2025, YOY growth averaged approximately 19%, propelled by early technological advances and increased funding. From 2025 through 2035, the market still records healthy double-digit growth, averaging 15%, supported by clinical integration and affordable platform launches. This consistent expansion underscores sustained demand and rapid market evolution.

The United States maintains the largest share of the North America Long Read Sequencing Market, owing to its strong biotechnology ecosystem, active research landscape, and major vendor presence. Canada follows, supported by expanding genomic medicine programs and government investments. Mexico's share is rising as healthcare and academic institutions adopt next-generation sequencing solutions, albeit at a slower pace compared to its northern counterparts.

PacBio and Oxford Nanopore Technologies lead the North America Long Read Sequencing Market, collectively holding the majority share. Their continued innovation and comprehensive platform offerings solidify their dominance. Illumina, while strong in short read sequencing, is growing its presence in long read applications through partnerships. Regional and emerging firms, such as BGI Genomics, round out the market landscape with tailored solutions.

Research institutes stand as the largest buyers of long read sequencing platforms in 2025, aligning with their focus on population genomics and discovery science. Hospitals and clinical labs are increasing adoption for diagnostic and oncology applications. Pharmaceutical and biotechnology companies represent a substantial share, leveraging long read technologies for drug development and biomarker discovery.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1192
Regions	United States, Canada, Mexico
Segments	By Type (SMRT Sequencing, Nanopore Sequencing, Synthetic Long-Read Sequencing, Linked-Read Sequencing, Hybrid Sequencing, Others); By Application (De Novo Sequencing, Variant Detection, Transcriptome Analysis, Epigenetics, Cancer Genomics, Others); By Technology (SMRT Sequencing, Nanopore Sequencing, Linked-Read Sequencing, Synthetic Long-Read Sequencing, Hybrid Sequencing, Others); By Distribution Channels (Direct Sales, Distributors, Online Sales, Research Institutes, Hospitals, Others); By Organization Size (Small, Medium, Large)
Players	PacBio, Oxford Nanopore Technologies, Illumina, BGI Genomics, Quantapore, Stratos Genomics, QIAGEN, Genapsys, Roche, Nabsys, Dovetail Genomics, Longas Technologies, Agilent Technologies, ZS Genetics, Other Key Players

June 2024: PacBio announced the release of its Revio system with upgraded chemistries, increasing yields in human whole genome sequencing.
July 2024: Oxford Nanopore Technologies entered a strategic partnership with a US cancer center to deploy rapid sequencing for real-time oncology diagnostics.
August 2024: BGI Genomics expanded its North America presence by unveiling cloud-enabled genomic analytics specifically optimized for long read sequencing data.
September 2024: Roche collaborated with several major hospital networks to introduce long read sequencing workflows in hereditary cancer screening.
November 2024: Genapsys launched a simplified data analysis toolkit to accelerate interpretation of large-scale long read sequencing datasets for academic and clinical use.

About the Author

Sophia

Lead Industry Analyst

Sophia is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Sophia brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Sophia has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Buy Now

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

North America Long Read Sequencing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Long Read Sequencing Market Analysis 2025–2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Long Read Sequencing Market Share by Type, 2025

North America Long Read Sequencing Market Share by Application, 2025

North America Long Read Sequencing Market Revenue (USD Million), 2020-2035

North America Long Read Sequencing Market YOY Growth (%), 2020-2035

North America Long Read Sequencing Market Share by Region, 2025

North America Long Read Sequencing Market Share by Players, 2025

North America Long Read Sequencing Market Share by Buyers, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports